CVC raised Recordati offer to EUR 53 as Recordati stock neared bid
Published on 10/12/2026 at 10:35 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKey points in brief
- CVC raised its Recordati takeover offer from EUR 51.29 to EUR 53 per share on October 6, 2026.
- The acceptance deadline is October 23, 2026, with payment scheduled for November 2, 2026.
- Recordati stock was at EUR 52.98 at Lang & Schwarz on October 12, 2026 at 10:31 a.m. CEST.
- The offer includes a EUR 0.71 dividend and 49.79 percent of shares had been tendered by October 5, 2026.
Recordati (ISIN IT0003828271) was trading at EUR 52.98 at Lang & Schwarz on October 12, 2026 at 10:31 a.m. CEST, while the takeover offer from CVC Capital Partners and Groupe Bruxelles Lambert stands at EUR 53 per share. Reuters reported on October 6, 2026, that Respighi BidCo raised the cash offer from EUR 51.29 to EUR 53 and extended the acceptance period.
Three dates define the bid
The offer period began on August 31, 2026, with the original EUR 51.29 consideration, according to Reuters. By October 5, 2026, shareholders representing 49.79 percent of Recordati's share capital had tendered their shares. On October 6, 2026, the consortium lifted the offer to EUR 53 per share and described it as its best and final proposal.
What does the higher offer include?
The revised consideration includes EUR 0.71 per share from Recordati's 2025 dividend, bringing the total value to EUR 53.71 per share, Reuters reported. The offer is aimed at taking Recordati private, so the key valuation issue is whether the final bid adequately reflects the pharmaceutical group's stand-alone prospects.
Il Sole 24 ORE reported on October 6, 2026, that the bid followed opposition from minority shareholders and independent directors, who considered the earlier terms financially inadequate. That history makes the EUR 53 ceiling central to the investment case: the consortium has raised the price, but has also ruled out a further increase.
Deadline and payment date
Reuters reported that the acceptance deadline moved from October 15 to October 23, 2026, while payment is scheduled for November 2, 2026. The timetable leaves the offer price and shareholder tender rate as the two clearest figures for assessing the path toward delisting.
Recordati stock near the offer
Recordati's latest Lang & Schwarz price of EUR 52.98 is EUR 0.02 below the EUR 53 cash offer, a gap of 0.04 percent measured against the offer price. Recordati says it is a global pharmaceutical company with more than 4,700 employees operating in 150 countries, according to its investor-relations page.
The current price was EUR 52.98 at Lang & Schwarz on October 12, 2026 at 10:31 a.m. CEST.
The further course of trading is shown by the continuously updated real-time quote of Recordati stock.
Recordati stock facts
- Company: Recordati Industria Chimica e Farmaceutica S.p.A.
- ISIN: IT0003828271
- Ticker: REC.MI
- Primary exchange: Borsa Italiana
- Price Lang & Schwarz (as of October 12, 2026, 10:31 a.m. CEST): EUR 52.98
- Sector / Industry: Healthcare / Medical Pharmaceuticals
Market context: Market report FTSE MIB.
